Gossamer Bio regains Nasdaq minimum bid price compliance after 1-for-80 reverse split

Gossamer Bio, Inc.

Gossamer Bio received a Sept. 25, 2026 Nasdaq letter stating it regained compliance with Nasdaq Listing Rule 5450(a)(1) minimum bid price requirement.
Nasdaq's April 8, 2026 letter had flagged noncompliance because GOSS common stock traded below $1.00 for 30 consecutive business days.
Gossamer effected a 1-for-80 reverse stock split on Sept. 10, 2026, and GOSS began trading split-adjusted on Nasdaq on Sept. 11, 2026.
The Nasdaq minimum bid price matter is now closed, according to the Sept. 25, 2026 letter.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.